The SDHAF1 Gene Mitochondrial Complex II Deficiency Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the SDHAF1 gene. These mutations are associated with mitochondrial complex II deficiency, a rare genetic disorder that affects cellular energy production. The test is crucial for diagnosing the condition early, allowing for timely intervention and management.
Mitochondrial complex II, also known as succinate dehydrogenase, plays a vital role in the mitochondrial respiratory chain, which is essential for energy production within cells. Mutations in the SDHAF1 gene can impair the function of complex II, leading to a variety of symptoms including developmental delay, muscle weakness, and respiratory problems, among others. Early diagnosis through genetic testing can significantly impact the management of the disorder, improving the quality of life for affected individuals.
The test is performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing services. The cost of the SDHAF1 Gene Mitochondrial Complex II Deficiency Genetic Test is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis to detect any mutations in the SDHAF1 gene. Results from the test can provide valuable information for families, enabling informed decisions about treatment options and potential interventions.
The SDHD Gene Mitochondrial Complex II Deficiency Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the SDHD gene that can lead to mitochondrial complex II deficiency. This condition is part of a group of disorders that affect the mitochondrial respiratory chain, crucial for energy production in cells. Mutations in the SDHD gene can disrupt this process, leading to a variety of symptoms, including muscle weakness, neurodegenerative issues, and in severe cases, organ failure.
The test is crucial for individuals showing symptoms suggestive of mitochondrial disorders or for those with a family history of such conditions. Early detection through this genetic test can aid in the management and treatment planning for affected individuals, potentially improving quality of life and outcomes.
DNA Labs UAE offers this test at a cost of 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for the presence of mutations in the SDHD gene. The results from this test can provide valuable information for patients and healthcare providers, guiding decisions on treatment and management of the condition.
The BCS1L Gene Mitochondrial Complex III Deficiency Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the BCS1L gene. These mutations can lead to mitochondrial complex III deficiency, a rare genetic disorder that affects the body's energy production. Mitochondrial complex III is crucial for the mitochondrial respiratory chain, which generates the majority of the cell's energy through a process called oxidative phosphorylation. Deficiencies in this complex can lead to a wide range of symptoms, including muscle weakness, heart problems, growth delay, and liver disease, varying significantly from person to person.
The test involves analyzing the patient's DNA to identify any genetic alterations in the BCS1L gene that might be causing the deficiency. This is critical for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions. At DNA Labs UAE, the cost for the BCS1L Gene Mitochondrial Complex III Deficiency Genetic Test is 4400 AED. This investment in health allows for a precise diagnosis, facilitating targeted management and intervention strategies for affected individuals and their families, potentially improving the quality of life and outcomes for those with this challenging condition.
The STAMBP Gene Microcephaly-Capillary Malformation Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the STAMBP gene, which are associated with Microcephaly-Capillary Malformation Syndrome (MIC-CAP). This rare genetic disorder is characterized by microcephaly, where an infant's head is significantly smaller than expected, and capillary malformations, which are distinctive, small, red to purple spots on the skin. The condition may also involve a range of other physical and developmental challenges.
DNA Labs UAE provides this crucial genetic testing service for a fee of 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in their state-of-the-art laboratory. The aim is to detect any abnormalities in the STAMBP gene that could indicate the presence of MIC-CAP syndrome. This information is vital for early diagnosis, which can significantly impact the management and treatment of the condition, allowing healthcare providers to offer targeted support and interventions to improve the quality of life for affected individuals and their families.
The "RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at identifying mutations in the RYR1 gene, which are known to cause Minicore Myopathy with External Ophthalmoplegia. This condition is a rare genetic disorder characterized by muscle weakness, respiratory issues, and external ophthalmoplegia, which is a condition affecting eye movement. The RYR1 gene plays a crucial role in muscle contraction, and mutations in this gene can lead to the aforementioned symptoms.
The genetic test involves analyzing the patient's DNA to detect abnormalities in the RYR1 gene, providing valuable information for diagnosis, treatment planning, and genetic counseling. It is particularly useful for families with a history of the disorder, offering insights into the risk of passing the condition to offspring.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the testing and the comprehensive analysis required to accurately identify mutations in the RYR1 gene. Conducted at DNA Labs UAE, the test represents an important resource for individuals and families affected by Minicore Myopathy with External Ophthalmoplegia, facilitating early diagnosis and intervention for this rare condition.
The "DCC Gene Mirror Movements Type 1 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DCC gene, which are linked to Mirror Movements Type 1 disorder. This condition is characterized by involuntary movements on one side of the body that mirror intentional movements on the opposite side, often affecting the hands and limbs. Such mutations can lead to disruptions in the normal development of nerve fibers, affecting coordination and movement.
Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any genetic anomalies in the DCC gene, providing crucial information for the diagnosis, management, and understanding of the disorder. Conducted in the advanced facilities of DNA Labs UAE, the test is a vital tool for individuals experiencing symptoms of mirror movements, offering them a clear genetic insight into their condition and guiding their treatment options.
The "RAD51 Gene Mirror Movements Type 2 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the RAD51 gene, which are linked to the development of Mirror Movements Type 2. This condition is characterized by involuntary symmetrical movements of one side of the body mirroring intentional movements on the opposite side. The test is crucial for individuals exhibiting symptoms of this disorder or those with a family history, as it aids in confirming the diagnosis and facilitating appropriate management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific genetic alterations in the RAD51 gene that are associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations.
Early detection through the RAD51 Gene Mirror Movements Type 2 Genetic Test can significantly benefit affected individuals by enabling timely intervention and support, thereby improving quality of life and reducing the risk of complications associated with uncoordinated movements.
The "DNAL4 Gene Mirror Movements Type 3 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the DNAL4 gene associated with Mirror Movements Type 3. This condition is characterized by involuntary mirroring of movements in symmetrical limbs, often noticeable when an individual attempts to perform unilateral tasks. The test plays a crucial role in the accurate diagnosis and understanding of the genetic basis of this rare disorder, facilitating tailored management and therapy options for affected individuals.
Administered with precision and care at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. Advanced genetic sequencing techniques are then employed to scrutinize the DNAL4 gene for specific mutations that contribute to the development of Mirror Movements Type 3.
Priced at 4400 AED, the test represents a significant step towards personalized medicine, offering insights that can guide healthcare professionals in crafting bespoke treatment plans. It also provides valuable information for affected families regarding the inheritance patterns and potential implications for future generations.
The FOXRED1 Gene Mitochondrial Complex I Deficiency Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FOXRED1 gene, which are associated with mitochondrial complex I deficiency. This condition is a rare genetic disorder that affects the mitochondrial respiratory chain, leading to a range of clinical manifestations including muscle weakness, heart disease, and neurological deficits. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic variations in the FOXRED1 gene that might disrupt the normal function of complex I, one of the key enzymes involved in cellular energy production. This precise genetic testing is crucial for confirming a diagnosis, guiding treatment options, and providing information on the risk of passing the condition to future generations. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, supporting patients and their families in managing and understanding their genetic health.
The "MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MT-ND1 gene. This gene plays a crucial role in the proper functioning of Complex I, a key enzyme complex in the mitochondrial respiratory chain responsible for energy production in cells. Mutations in the MT-ND1 gene can lead to mitochondrial complex I deficiency, a condition that can cause a wide range of symptoms, including muscle weakness, neurological problems, and organ dysfunction. This genetic test is vital for the early detection and management of the condition, facilitating personalized treatment plans to improve patient outcomes. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the mitochondrial DNA. Conducted at DNA Labs UAE, this test represents a crucial step forward in the diagnosis and management of mitochondrial disorders, offering hope to affected individuals and their families.
